ICAM1 and amyotrophic lateral sclerosis: These data suggest that ALS patient (TARDBPN345K/+)-derived EECM-BMEC-like cells express enhanced ICAM-1 and VCAM-1, which may contribute to immune cell trafficking into the CNS.